Profilo
Jerry Cacia worked as the Global Head of Pharmaceutical Technical Development at Genentech, Inc. from 1988 to 2016.
He then served as the Head of Biologics & Drug Product Manufacturing at F.
Hoffmann-La Roche Ltd. from 2016 to 2021.
Currently, he is the Chief Technical Officer at Graphite Bio, Inc. since 2021.
Mr. Cacia completed his undergraduate degree at the University of California, Santa Cruz.
Precedenti posizioni note di Jerry Cacia
| Società | Posizione | Fine |
|---|---|---|
| LENZ THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2023 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/02/2021 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Jerry Cacia
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of California, Santa Cruz
University of California, Santa Cruz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
















